Skip to main content
HBsAg and HCV Combo Test Cassette (S/P)

HBsAg and HCV Combo Test Cassette (S/P)

HBsAg and HCV Combo Test Cassette (S/P) by LARKSOIS Pharma is a professional infectious disease rapid test designed for the qualitative detection of Hepatitis B surface antigen (HBsAg) and antibodies to Hepatitis C Virus (HCV) in human serum or plasma specimens. The test is based on a rapid chromatographic immunoassay method and supports quick preliminary screening for two major viral hepatitis markers in one cassette.

Description

HBsAg and HCV Combo Test Cassette (S/P)

Category

INFECTIOUS DISEASE

Method

Rapid Test

Cut-Off

N/A

Introduction

  • The HBsAg and HCV Combo Test Cassette (S/P) is a professional infectious disease rapid test developed for qualitative screening of two important viral hepatitis markers.
  • This combo cassette is designed to detect Hepatitis B surface antigen and antibodies to Hepatitis C Virus in serum or plasma specimens.
  • The test supports hospitals, diagnostic laboratories, clinics, blood screening support programs, public health testing programs, and point-of-care testing environments.
  • The HBsAg and HCV Combo Test Cassette provides preliminary qualitative screening results and should be interpreted by healthcare professionals together with patient history, clinical findings, risk assessment, and confirmatory testing where required.

What Does Detect

  • HBsAg – Hepatitis B Surface Antigen: HBsAg is a marker used in screening for Hepatitis B Virus infection. The HBsAg section helps detect Hepatitis B surface antigen in the specimen.
  • HCV Antibodies: The HCV section detects antibodies to Hepatitis C Virus. HCV antibody testing helps identify individuals who may need further confirmatory testing.
  • By combining both markers in one cassette, the HBsAg and HCV Combo Test Cassette (S/P) supports efficient infectious disease screening, especially where quick results and streamlined testing are important.

Importance

  • Hepatitis B and Hepatitis C are major global liver infections. Both may remain silent for a long time, which makes screening important in healthcare systems.
  • A rapid test cassette helps support early identification of reactive samples and allows healthcare providers to recommend further evaluation.
  • The HBsAg and HCV Combo Test Cassette is useful for viral hepatitis screening, clinical diagnostic support, public health testing programs, pre-procedure screening support, blood safety screening support, laboratory workflow improvement, and international diagnostic procurement.
  • This test provides preliminary results only. Reactive results should be confirmed with approved laboratory methods and interpreted with clinical history.

Intended Use

The HBsAg and HCV Combo Test Cassette (S/P) by LARKSOIS Pharma may be used in professional diagnostic and healthcare environments.

Applications

  • Viral hepatitis screening
  • Hospitals and clinical laboratories
  • Diagnostic centers and clinics
  • Blood screening support programs
  • Public health testing programs
  • Point-of-care testing workflows
  • Pre-procedure screening support
  • International diagnostic distribution
  • Healthcare procurement and supply channels

How It Works

  • The HBsAg and HCV Combo Test Cassette (S/P) works on a rapid chromatographic immunoassay principle.
  • The serum or plasma specimen moves along the membrane by capillary action.
  • If HBsAg or HCV antibodies are present, they react with specific test components and form visible colored lines in the relevant test regions.
  • A control line confirms proper sample flow and valid test performance. Results should always be read according to the official LARKSOIS Pharma product insert.

Method

The HBsAg and HCV Combo Test Cassette uses rapid chromatographic immunoassay technology for qualitative detection of Hepatitis B surface antigen and Hepatitis C antibodies.

Benefits

  • Detects HBsAg and HCV antibodies in one cassette
  • Uses serum or plasma specimen
  • Rapid chromatographic immunoassay method
  • Easy visual result interpretation
  • No major instrument required
  • Designed for professional use
  • Useful for infectious disease screening
  • Suitable for international healthcare markets
  • Supports fast preliminary decision-making

Specimen

The HBsAg and HCV Combo Test Cassette (S/P) is designed for serum or plasma specimens. Correct specimen collection and handling are important for reliable screening performance.

Guidance

  • Use serum or plasma specimens only for this S/P format
  • Collect specimens according to the product insert
  • Use clean and suitable specimen collection materials
  • Avoid contaminated or improperly stored samples
  • Bring the test cassette and specimen to room temperature if required
  • Apply the required specimen volume as instructed
  • Add buffer if required by the kit instructions
  • Read results only within the recommended time window
  • Treat all specimens as potentially infectious material

Note

Specimen collection, handling, timing, and storage should always follow the official LARKSOIS Pharma kit insert.

Detection Markers

Instructions

  • HBsAg – Hepatitis B surface antigen
  • HCV Ab – Antibodies to Hepatitis C Virus

Note

Exact performance characteristics, sensitivity, specificity, cross-reactivity, and interpretation details should follow the final product insert and technical documentation.

Clinical Importance

  • HBsAg and HCV screening is important because Hepatitis B and Hepatitis C may have serious liver-related health consequences and may remain undetected without testing.
  • A combo cassette can help healthcare professionals screen two viral hepatitis markers in one rapid test format.
  • Reactive results should not be treated as final diagnosis. They should be confirmed using approved laboratory methods and interpreted with clinical history, exposure risk, and local diagnostic guidelines.
  • Healthcare professionals should decide diagnosis, counseling, and follow-up based on complete clinical evaluation.

Limitations

The HBsAg and HCV Combo Test Cassette is intended as a qualitative screening aid and should not be used as the only basis for diagnosis or treatment decisions.

Instructions

  • Reactive results are preliminary and require further testing where applicable
  • Non-reactive results do not always rule out infection
  • Testing too early after exposure may affect detection
  • Improper specimen collection or storage may affect results
  • Expired or poorly stored kits may affect performance
  • Results should be interpreted with clinical findings and risk assessment
  • Confirmatory testing should be performed according to local diagnostic guidelines

Key Features

Instructions

  • Detects HBsAg and HCV antibodies in one cassette
  • Uses serum or plasma specimen
  • Rapid chromatographic immunoassay method
  • Easy visual result interpretation
  • No major instrument required
  • Designed for professional use
  • Useful for infectious disease screening
  • Suitable for international healthcare markets
  • Supports fast preliminary decision-making

Note

The HBsAg and HCV Combo Test Cassette by LARKSOIS Pharma is developed for professional users who need fast and practical viral hepatitis screening support.

Procedure

Steps

  • Bring the test cassette and specimen to room temperature if required
  • Remove the cassette from the sealed pouch only when ready to test
  • Place the cassette on a clean, flat surface
  • Add the required amount of serum or plasma to the sample well
  • Add buffer if required by the kit instructions
  • Wait for the recommended reaction time
  • Read the test and control lines within the stated time window
  • Do not interpret results after the recommended reading time
  • Dispose of used materials according to laboratory safety rules

Note

The exact procedure must follow the official LARKSOIS Pharma product insert supplied with the HBsAg and HCV Combo Test Cassette (S/P).

Result Interpretation

Positive

A reactive or positive result usually shows a control line and a test line in either the HBsAg or HCV region. This suggests a reactive result for that marker. Reactive results should be confirmed using approved laboratory methods.

Negative

A non-reactive or negative result usually shows only the control line. This suggests that HBsAg and HCV antibodies were not detected by the rapid test at the time of testing. A non-reactive result does not always rule out infection.

Invalid

If the control line does not appear, the result is invalid. The test should be repeated with a new cassette and properly collected specimen according to the product insert.

Storage

Instructions

  • Store according to the product label and package insert
  • Keep cassette sealed until use
  • Protect from moisture
  • Do not freeze
  • Avoid direct sunlight
  • Do not use expired or damaged kits
  • Use immediately after opening the pouch
  • Follow the temperature range mentioned on the product label

Precautions

Instructions

  • For professional in-vitro diagnostic use only
  • Use serum or plasma specimens only for this S/P format
  • Handle all specimens as potentially infectious
  • Wear gloves during testing
  • Do not reuse the cassette
  • Do not mix components from different lots
  • Do not use damaged or expired kits
  • Read results only within the recommended time
  • Follow local biosafety and disposal guidelines
  • Confirm reactive results with further testing where required

Why Choose

LARKSOIS Pharma provides internationally focused diagnostic and healthcare products for hospitals, clinics, laboratories, importers, distributors, and public health buyers. The HBsAg and HCV Combo Test Cassette (S/P) is designed to support fast, practical, and reliable infectious disease screening.

Advantages

  • International diagnostic product focus
  • Reliable rapid testing solutions
  • Suitable for hospitals, clinics, and laboratories
  • Distributor-friendly product format
  • Supports infectious disease screening workflows
  • Practical two-marker combo testing format
  • Quality-focused standards under LARKSOIS Pharma

Frequently Asked Questions

What is the principle of the HBsAg test?+

The HBsAg test works on a chromatographic immunoassay principle. If Hepatitis B surface antigen is present in the specimen, it reacts with specific antibodies and forms a visible test line.

What is the HBsAg HCV test?+

The HBsAg HCV test is a rapid screening test used to detect Hepatitis B surface antigen and antibodies to Hepatitis C Virus in serum or plasma samples.

What is the principle of HCV test kit?+

The HCV test kit uses an immunochromatographic method to detect antibodies to Hepatitis C Virus. A visible line appears when HCV antibodies are present in the tested specimen.

What is a 5 panel test for hepatitis?+

A 5 panel hepatitis test usually refers to a group of blood tests used to evaluate hepatitis infection or immunity, commonly including markers related to Hepatitis A, B, and C.

What are the 4 types of hepatitis?+

Common viral hepatitis types include Hepatitis A, B, C, D, and E. In many screening contexts, A, B, C, and E are frequently discussed.